Presentations

Virtual 23rd International AIDS Conference held on July 6-10, 2020

July 6, 2020
  1. Ueaphongsukkit T, Han WM, Gatechompol S, Sophonphan J, Kerr SJ, Ubolyam S, Phonphithak S, Tangkijvanich P, Avihingsanon A, HIV-NAT 006/207 study team. Diabetes Mellitus is associated with incident liver cirrhosis in people living with HIV in Thailand: a prospective cohort analysis.
  2. Apornpong T, Grinsztejn B, Hughes M, Okochi H, Ritz J, Kerr S, Fletcher C, Ruxrungtham K, Godfrey C, Gross R, Hogg E, Wallis C, Badal-Faesen S, Hosseinipour M, Mngqbisa R, SantosB, Shah S, Hovind S, Mawlana S, Van Schalkwyk M, Chotirosniramit N, Kanyama C, Kumarasamy N, Salata R, Collier A, Gandhi M, for A5288 study team. Hair Concentration of Antiretroviral Drugs, but Not Self-Reported Adherence, is Associated with Ongoing Virologic Failure among Individuals in Resource Limited Settings (RLS) on Second Line Antiretroviral Therapy (ART).
  3. Han WM, Jiamsakul A, Salleh NAM, Choi JY, vu huy B, Yunihastuti E, Do CD, Merati TP, Gani YM, Kiertiburanakul S, Zhang F, Chan Y, Lee M, Chaiwarith R, Ng OT, SKhusuwan S, Ditangco R, Kumarasamy N, Sangle S, Ross J, Avihingsanon A, on behalf of IeDEA Asia-Pacific. HIV treatment outcomes among people who inject drugs in the Asia-Pacific region: an observational cohort study.
  4. Han WM, Bijker R, Chandrasekaran E, Mation ML, Pujari S, Ng OT, Ly PS, Lee M, Nguyen KV, Chan Y, Do CD, Choi JY, Chaiwarith R, Merati TP, Kiertiburanakul S, Azwa I, Khusuwan S, Zhang F, Gani YM, Tanuma J, Sangle S, Yunihastuti E, Ross J, Avihingsanon A, on behalf of IeDEA Asia-Pacific. Validation of the D:A:D Chronic Kidney Disease Risk Score Model among people living with HIV in the Asia-Pacific.
  5. Malee K, Chettra K, Sophononphan J, Kosalaraksa P, Aurpibul L, Ounchanum P, Kanjanavanit S, Ngampiyaskul C, Sun Ly P, Thongpibul K, Paul R, Ananworanich J, Kerr SJ, Mellins CA, Puthanakit T. High levels of mental health resilience among adolescents living with HIV in Thailand and Cambodia. Oral abstract*
  6. Ubolyam S, Iampornsin T, Jaimulwong T, Supakawee K, Sophonphan J, Harnpariphan W, Supanun R, Mahanontharit A, Gatechumpol S, Kawkitinarong K, Ruxrungtham K, Phanuphak P, Kelleher AD, Avihingsanon A. Comparison of 3 immunodiagnostic tests for Latent Tuberculosis infection among Thai prisoners.
  7. Avihingsanon A, Hughes M, Salata R, Godfrey C, McCarthy C, Mugyenyi P, Hogg E, Gross R, Cardoso SW, Bukuru A, Makanga M, Faesen S, Mave V, Ndege BW, Fontain SN, Samaneka W, Secours R, van Schalkwyk M, Mngqibisa R, Mohapi L, Valencia J, SugandhavesaP, Montalban E, Okanda J, Munyanga C, Chagomerana MB, Santos BR, Kumarasamy N, Kanyama C, Schooley RT, Mellors JW, Wallis CL, Collier AC, Grinsztejn B, for the A5288 Study team. Third-line antiretroviral therapy including raltegravir, darunavir/ritonavir and/or etravirine is well tolerated and achieves durable virologic suppression over 144+ weeks in resource limited settings ACTG: A5288 strategy trial.
  8. Tankittiwat K, Tumkosit M, Chattranukilchai P, Siwamogsatham S, Apornpong T, Ureaphongsukkit T, Kerr SJ, Boonyaratavej S, Avihingsanon A and HIV-NAT 006/207 study team. Increased epicardial adipose tissue volume in virally suppressed older HIV-infected Asian and Relationships to central fat accumulation and lipodystrophy.
  9. Harnpariphan W, Han WM, Supanan R, Supakawee K, Ubolyam S, Wongsabut J, Gatechumpol S, Tangkijvanich P, Tanprasertsuk S, Ruxrungthan K, Phanuphak P, Avihingsanon A. High prevalence of HIV, viral hepatitis B, C and syphilis among male prisoners in Thailand.
  10. Teeraananchai S, Kerr SJ, Ruxrungtham K, Thammatacharee J, Khananurak P, Puthanakit T. The HIV treatment cascade in the era of rapid antiretroviral initiation among behavioral HIV-infected youth through the National AIDS program in Thailand.